Southern Capital Advisors LLC Buys 448 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Southern Capital Advisors LLC raised its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 1.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,280 shares of the company’s stock after acquiring an additional 448 shares during the quarter. iShares U.S. Pharmaceuticals ETF makes up 1.6% of Southern Capital Advisors LLC’s investment portfolio, making the stock its 18th largest position. Southern Capital Advisors LLC owned 0.40% of iShares U.S. Pharmaceuticals ETF worth $2,844,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Janney Montgomery Scott LLC boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 3.0% during the first quarter. Janney Montgomery Scott LLC now owns 12,489 shares of the company’s stock valued at $848,000 after purchasing an additional 358 shares in the last quarter. &PARTNERS purchased a new stake in iShares U.S. Pharmaceuticals ETF during the second quarter valued at $267,000. Marshall Wace LLP purchased a new stake in iShares U.S. Pharmaceuticals ETF during the second quarter valued at $422,000. Texas Yale Capital Corp. lifted its holdings in iShares U.S. Pharmaceuticals ETF by 179.2% in the first quarter. Texas Yale Capital Corp. now owns 13,430 shares of the company’s stock valued at $912,000 after acquiring an additional 8,620 shares during the period. Finally, Comerica Bank boosted its position in iShares U.S. Pharmaceuticals ETF by 71.6% in the first quarter. Comerica Bank now owns 1,462 shares of the company’s stock worth $99,000 after purchasing an additional 610 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Up 0.7 %

NYSEARCA IHE opened at $70.10 on Monday. The company has a 50-day moving average price of $71.20 and a 200-day moving average price of $68.10. iShares U.S. Pharmaceuticals ETF has a 52 week low of $55.36 and a 52 week high of $72.94. The firm has a market capitalization of $708.01 million, a P/E ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.